Opposing effects of isoflurane and sevoflurane on neurogenic pulmonary edema development in an animal model

Anesthesiology

Volumn 102, Issue 6, 2005, Pages 1182-1189

  Kandatsu, Nobuhisa ^a   Nan, Yong Shan ^a,b   Feng, Quo Gang ^a   Nishiwaki, Kimitoshi ^a,b   Hirokawa, Mitsuru ^a   Ishikawa, Kiyonori ^a   Komatsu, Toru ^a   Yokochi, Takashi ^a   Shimada, Yasuhiro ^a,b   Ishikawa, Naohisa ^a,c  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; INHALATION ANESTHETIC AGENT; ISOFLURANE; MESSENGER RNA; PENTOBARBITAL; POLYCLONAL ANTIBODY; SEVOFLURANE; THROMBIN; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CISTERNA MAGNA; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; INHALATION ANESTHESIA; LUNG EDEMA; LUNG FLUID; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ISOFLURANE; MALE; METHYL ETHERS; PULMONARY EDEMA; RATS; RATS, WISTAR;

EID: 21144477804     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200506000-00018     Document Type: Article

References (32)

1. Malik AB: Mechanisms of neurogenic pulmonary edema. Circ Res 1985; 57:1-18
2. Hirabayashi A, Nishiwaki K, Shimada Y, Ishikawa N: Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema. Eur J Pharmacol 1996; 296:297-305
3. Hamdy O, Maekawa H, Shimada Y, Feng GG, Ishikawa N: Role of central nervous system nitric oxide in the development of neurogenic pulmonary edema in rats. Crit Care Med 2001; 29:1222-8
4. Nan YS, Feng GG, Hotta Y, Nishiwaki K, Shimada Y, Ishikawa A, Kurimoto N, Shigei T, Ishikawa N: Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer. Am J Physiol Heart Circ Physiol 2004; 286: H1027-33
5. Donoso MV, Miranda R, Irarrazaval MJ, Huidobro-Toro JP: Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission. J Vasc Res 2004; 41:387-99
6. Featherstone RM, Muehlbaecher CA: The current role of inert gases in the search for anesthesia mechanisms. Pharmacol Rev 1963; 15:97-121
7. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH: Transient increase in alveolar epithelial permeability induced by volatile anesthesia with isoflurane. Lung 2000; 178:129-35
8. 99mTcDTPA radioaerosol inhalation lung scan. Respiration 1999; 66:506-10
9. Shayevitz JR, Johnson KJ, Knight PR: Halothane- oxidant interactions in the ex vivo perfused rabbit lung: Fluid conductance and eicosanoid production. ANESTHESIOLOGY 1993; 79:129-38
10. Rezaiguia-Delclaux S, Tayr C, Luo DF, Saïdi NE, Meignan M, Duvaldestin P: Halothane and isoflurane decrease alveolar epithelial fluid clearance in rats. ANESTHESIOLOGY 1998; 88:751-60
11. Sakakibara H, Hashiba Y, Taki K, Kawanishi M, Shimada Y, Ishikawa N: Effects of sympathetic nerve stimulation on lung vascular permeability in the rat. Am Rev Resp Dis 1992; 145:685-92
12. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR: Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995; 107:233-5
13. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marme D: Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 1997; 57:5421-5
14. Physiological Society of Japan: Guiding principles for the care and use of animals in the field of physiological sciences [in Japanese]. Nippon Seirigaku Zasshi 2002; 64:143-6
15. Ishikawa N, Kainuma M, Furuta T, Sato Y: Factors influencing fibrin-induced pulmonary edema. Jpn J Pharmacol 1988; 46:255-60
16. 2+ signaling. Pflugers Arch 1999; 438:612-20
17. Nishiwaki K, Hirabayashi A, Shimada Y, Ishikawa N: Effects of vasodilators on fibrin-induced pulmonary edema, so-called neurogenic pulmonary edema, in the rat. J Anesth 1994; 8:208-12
18. Stoelting RK: Inhaled anesthetics, Pharmacology and Physiology in Anesthetic Practice, 2nd edition. Edited by Stoelting RK. Lippincott, 1991, pp 33-69
19. Hung CJ, Liu FY, Wu RS, Tsai JJ, Lin CC, Kao A.: The influence of volatile anesthetics on alveolar epithelial permeability measured by noninvasive radionuclide lung scan. Ann Nucl Med 2003; 17:213-8
20. Bruegger D, Bauer A, Finsterer U, Bernasconi P, Kreimeier U, Christ F: Microvascular changes during anesthesia: Sevoflurane compared with propofol. Acta Anaesthesiol Scand 2002; 46:481-7
21. Liu R, Ishibe Y, Ueda M: Isoflurane-sevoflurane administration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs. ANESTHESIOLOGY 2000; 92:833-40
22. Webb NJA, Myers CR, Watson CJ, Bottomley MJ, Brenchley PEC: Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 1998; 10:254-7
23. Elliott RH, Strunin L: Hepatotoxicity of volatile anesthetics. Br J Anaesth 1993; 70:339-48
24. Baumane L, Dzintare M, Zvejniece L, Meirena D, Lauberte L, Sile V, Kalvinsh I, Sjakste N: Increased synthesis of nitric oxide in rat brain cortex due to halogenated volatile anesthetics confirmed by EPR spectroscopy. Acta Anaesthesiol Scand 2002; 46:378-83
25. Kindler CH, Eilers H, Donohoe P, Ozer S, Bickler PE: Volatile anesthetics increase intracellular calcium in cerebrocortical and hippocampal neurons. ANESTHESIOLOGY 1999; 90:1137-45
26. Feng GG, Nishiwaki K, Kondo H, Shimada Y, Ishikawa N: Inhibition of fibrin-induced neurogenic pulmonary edema by previous unilateral left vagotomy correlates with increased levels of brain nitric oxide synthase in the nucleus tractus solitarii. Auton Neurosci 2002; 102:1-7
27. Kroll J, Waltenberger J: A novel function of VEGF receptor-2 (KDR): Rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun 1999; 265:636-9
28. Kurimoto N, Nan YS, Chen ZY, Feng GG, Komatsu T, Kandatsu N, Ko J, Kawai N, Ishikawa N: Effects of specific signal transductic inhibitors on increased permeability across rat endothelial monolayers, induced b neuropeptide Y or VEGF. Am J Physiol Heart Circ Physiol 2004; 287:H100-6
29. i. Am J Physiol Heart Circ Physiol 2000; 279:H1625-34
30. Bates DO, Curry FE: Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. Am J Physiol 1997; 273:H687-94
31. Murohari T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM: Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998; 97:99-107
32. Thickett DR, Armstrong L, Christie SJ, Millar AB: Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164:1601-5